1. Home
  2. Browse
  3. Psychiatry
  4. ADHD
  5. Treatment

Treatment

46 - 60 of 61 Results
Sort Results:
Guideline: Diagnosis and Management of ADHD (ICSI; March 2012) April 2011
Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (Correction) (June 2008) April 2011
Article: Kapvay (clonidine extended-release) for attention deficit hyperactivity disorder (ADHD) in children February 2011
Guideline: Diagnosis and Management of Attention Deficit Hyperactivity Disorder in Primary Care for School-Age Children and Adolescents (Updated 2012) February 2011
Guideline: Diagnosis and Management of ADHD in Children and Adolescents (ICSI) (Updated 2012) November 2009
Guideline: Assessment and Treatment of Children and Adolescents with ADHD (AACAP) (2007) November 2009
Article: Intuniv (in-TOO-niv), a new extended-release guanfacine for ADHD November 2009
Article: Stimulants work better than Strattera for treating ADHD in kids September 2008
Article: launch a "new and improved" formulation just before a drug gets generic competition September 2008
Chart: New Formulations of Old Drugs September 2008
Article: whether cardiac testing is required for children taking ADHD drugs June 2008
Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (2008) June 2008
Guideline: AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.) June 2008
Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (Correction) (2009) June 2008
Commentary: Cardiovascular Screening and Monitoring Of Children and Adolescents Receiving ADHD Drugs June 2008